Back to results
US 2024/0002850 A1Published application
SIRT1-saRNA Compositions and Methods of Use
AssigneeMina Therapeutics Limited
InventorsSiv Anita Hegre, Pinelopi Andrikakou, Vikash Reebye
Life of this patent
Estimating the term…
Abstract
The invention relates to a saRNAs useful in upregulating the expression of the SIRT1 gene and therapeutic compositions comprising the saRNA. Methods of using the saRNA and the therapeutic compositions are also provided.
Claims17
A synthetic isolated saRNA which up-regulates the expression of the SIRT1 gene, wherein the saRNA comprises a strand that is at least 80% complementary to a targeted sequence on the template strand of the SIRT1 gene, wherein the targeted sequence comprises the sequence of any one of SEQ ID No. 3-24.
Dependencies are inferred from the claim text.